Abstract

Carnosine is a natural dipeptide antioxidant. It is proved that it protects human’s cells from oxidative stress. However, it has a short lifetime in a human organism due to the carnosinase activity. In order to solve this problem we used carnosine encapsulated in liposomes. Thus, the aim of this study was the creation of a new liposomal carnosine drug form. We used two encapsulation methods that show different carnosine behavior: a passive and an active one. We took into account that conditions of obtaining liposomes such as lipid composition, pH and temperature are important. In this study the lipid composition providing the maximum encapsulation efficiency was determined. Dipalmitoylphosphotidylcholine (DPPC) and its mixture with cholesterol (Chol) wereused as composition lipids. It was shown that the active encapsulation method using the creation of ammonium sulphate pH gradient provided the best results: 41.7% encapsulation efficiency (according to NMR spectroscopy) when using DPPC:Chol (7:3) mixture as lipids. Moreover, the properties of the liposomes were studied. Using the dynamic light scattering and electron microscopy methods carnosine liposomes (DPPC:Chol) were shown to be spherical nanoparticles with an average size of 133 nm. Carnosine release kinetics studied with the use of a France’s cell showed that carnosine was released in 24 hours (liposomal composition DPPC:Chol was 7:3). A study of carnosinase action on liposomal carnosine showed that the maximum amount of carnosine remained unchanged in DPPC:Chol liposomes (7:3). The results of the study make it possible to conclude that liposomal carnosine has a better activity in the human organism.

Highlights

  • In order to solve this problem we used carnosine encapsulated in liposomes

  • The aim of this study was the creation of a new liposomal carnosine drug form

  • A study of carnosinase action on liposomal carnosine showed that the maximum amount of carnosine remained unchanged in DPPC:Chol liposomes (7:3)

Read more

Summary

ХИМИЯ И ТЕХНОЛОГИЯ ЛЕКАРСТВЕННЫХ ПРЕПАРАТОВ И БИОЛОГИЧЕСКИ АКТИВНЫХ СОЕДИНЕНИЙ

В результате показано, что использование метода активной загрузки с помощью создания градиента pH сульфатом аммония позволяет получить липосомы с максимально возможной эффективностью включения, равной 41.7% (по данным 1Н-ЯМР-спектроскопии) при использовании в качестве липидов смеси ДПФХ-ХС (7:3). Исследование действия карнозиназы на липосомальный карнозин выявило, что большее количество карнозина сохранялось в неизменном виде при использовании липосом с липидным составом ДПФХ-ХС. Carnosine release kinetics studied with the use of a France’s cell showed that carnosine was released in 24 hours (liposomal composition DPPC:Chol was 7:3). Что эффективность включения карнозина уменьшалась в ряду липосом следующим образом: ДПФХ>ПОФХ >ДОФХ и составила, соответственно, 21.96, 18.86 и 17.12%. Целью настоящей работы являлась оптимизация способа получения липосомальных форм карнозина, обладающих большей эффективностью его включения, изучение их морфологии и размеров, а также определение кинетики высвобождения карнозина из липосом и действия карнозиназы на липосомальный карнозин

Экспериментальная часть
Результаты и обсуждение
Findings
Список литературы
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.